NATIONAL HEALTH INVESTORS INC
For the period ended Mar 31, 2026. Filed May 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 4, 2026
NHI$67.79-4.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Equity
| | |||||||
|---|---|---|---|---|---|---|---|
| Capital in | |||||||
| Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total | |||||||
| Shares | Amount | Par Value | Earnings | Dividends | Interests | Equity | |
| Balances at December 31, 2025 | 48,302,944 | $483 | $1,922,713 | $2,747,006 | $(3,148,659) | $8,166 | $1,529,709 |
| Net income, excluding a net loss of $256 attributable | |||||||
| to redeemable noncontrolling interest | — | — | — | 40,102 | — | (94) | 40,008 |
| Share-based compensation expense | — | — | 2,240 | — | — | — | 2,240 |
| Grants of restricted stock awards | 39,997 | — | — | — | — | — | — |
| Shares issued due to stock options exercised | 118,377 | 2 | — | — | — | — | 2 |
| Taxes paid related to net settlement of stock | |||||||
| incentive awards | (1,949) | — | (4,502) | — | — | — | (4,502) |
| Distributions declared to noncontrolling interests, | |||||||
| excluding $17 attributable to redeemable | |||||||
| noncontrolling interest | — | — | — | — | — | (235) | (235) |
| Dividends declared, $0.92 per share | — | — | — | — | (44,610) | — | (44,610) |
| Balances at March 31, 2026 | 48,459,369 | $485 | $1,920,451 | $2,787,108 | $(3,193,269) | $7,837 | $1,522,612 |
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
| | |||||||
|---|---|---|---|---|---|---|---|
| Capital in | |||||||
| Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total | |||||||
| Shares | Amount | Par Value | Earnings | Dividends | Interests | Equity | |
| Balances at December 31, 2024 | 45,687,942 | $457 | $1,736,831 | $2,604,829 | $(2,975,642) | $8,912 | $1,375,387 |
| Net income, excluding a net loss of $243 attributable | |||||||
| to redeemable noncontrolling interest | — | — | — | 34,165 | — | (105) | 34,060 |
| Issuance of common shares, net | 960,000 | 10 | 65,473 | — | — | — | 65,483 |
| Equity issuance costs | — | — | (47) | — | — | — | (47) |
| Share-based compensation expense | — | — | 2,558 | — | — | — | 2,558 |
| Grants of restricted stock awards | 29,500 | — | — | — | — | — | — |
| Shares issued due to stock options exercised | 16,763 | — | — | — | — | — | — |
| Taxes paid related to net settlement of stock | |||||||
| incentive awards | (534) | — | (136) | — | — | — | (136) |
| Distributions declared to noncontrolling interests, | |||||||
| excluding $7 attributable to redeemable | |||||||
| noncontrolling interest | — | — | — | — | — | (236) | (236) |
| Dividends declared, $0.90 per share | — | — | — | — | (42,024) | — | (42,024) |
| Balances at March 31, 2025 | 46,693,671 | $467 | $1,804,679 | $2,638,994 | $(3,017,666) | $8,571 | $1,435,045 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.